Código QR

Identification of novel inhibitors targeting Mycobacterium abscessus InhA through virtual screening, docking, and molecular dynamic simulations

Abstract Effective treatment options for Mycobacterium abscessus (MAB) pulmonary diseases (PD) are limited due to inadequate drug efficacy, rising drug resistance, and genetic mutations. New compounds are urgently needed to treat MAB-PD. The MAB Enoyl Acyl Carrier Protein (ACP) Reductase InhA (MAB-I...

Descrición completa

Gardado en:
Principais autores: Munawar Abbas, Abdullah R. Alanzi, Kashif Iqbal Sahibzada, Mariyam Nawaz, Ghulam Fatima, Dong-Qing Wei
Formato: Artigo
Idioma:Inglês
Publicado: Nature Portfolio 2025-04-01
Series:Scientific Reports
Assuntos:
Mycobacterium abscessus
MD simulations
InhA
Pharmacophore
Bioactive
Inhibitors
Acceso en liña:https://doi.org/10.1038/s41598-025-97513-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares